SCHEMBL29830596

SCHEMBL29830596

COc1nc(F)c(N)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 6/20 0.39
MAPT P10636 1/20 0.34
CASP1 P29466 1/20 0.34
ALDH1A1 P00352 3/20 0.33
AURKA O14965 1/20 0.33
TTK P33981 1/20 0.33
AURKB Q96GD4 1/20 0.33
INCENP Q9NQS7 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
P2RX3 P56373 1/20 0.32
P2RX2 Q9UBL9 1/20 0.32
CFTR P13569 2/20 0.31
TAAR1 Q96RJ0 1/20 0.31
MAPK8 P45983 1/20 0.31
MAPK9 P45984 1/20 0.31
PIK3R1 P27986 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23620161 1.00 PIK3CA (0.39) PIK3CAMAPTCASP1ALDH1A1AURKA
SCHEMBL29091371 0.87 MAPT (0.38) PIK3CAMAPTCASP1ALDH1A1AURKA
SCHEMBL23620104 0.84 PIK3CA (0.40) PIK3CAMAPTCASP1ALDH1A1AURKA
SCHEMBL24339192 0.82 ALDH1A1 (0.34) PIK3CAMAPTALDH1A1L3MBTL1
SCHEMBL23525716 0.82 POLB (0.44) PIK3CAMAPTCASP1AURKATTK
SCHEMBL22833318 0.81 PIK3CA (0.44) PIK3CAMAPTCASP1PIK3R1
SCHEMBL15244133 0.79 ALDH1A1 (0.39) PIK3CAMAPTCASP1ALDH1A1AURKA
SCHEMBL7168041 0.78 PIK3CA (0.39) PIK3CAMAPTCASP1ALDH1A1AURKA
SCHEMBL21199706 0.75 AXL (0.46) CYP3A4
SCHEMBL23620200 0.75 MAPT (0.33) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112469710-B Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2024-05-14 CN disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
EP-4074703-B1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2023-11-29 EP disclosed
EP-4074703-A1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2022-10-19 EP disclosed
EP-3810591-B1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2022-08-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides GPR17, GPR18, GPR119 PIK3CA 2852/4885MAPT 3406/4885CASP1 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.